Just reported
From The Cigna's results release of 5 Kasım 2026; its quarterly report has since been filed.
Actual
$73,68B
+%5,6 y/y
+%2,8 q/q
Guided
—
No guide given
Actual
$5,47
-%22 y/y
-%13 q/q
Guided
—
No guide given
Actual
$2,4B
-%7,1 y/y
-%10 q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Gelir payları three months ended June 30, 2026 dönemi için tahmindir; resmî bir bildirimden alınmış rakamlar değildir.
Express Scripts pharmacy benefit services
Manages prescription claims and pharmacy networks for client health plans, helps clients choose which drugs their plans cover, and negotiates drug discounts and rebates.
Accredo Specialty Pharmacy
Dispenses medicines for complex or rare conditions and provides patients with support from pharmacists, clinicians and in-home nursing services.
CuraScript SD
Supplies specialty medicines and medical products directly to hospitals, clinics and other health care providers.
Cigna employer health plans
Medical insurance and plan-administration services for employers, with options for employers that pay their employees' medical claims themselves.
International Health coverage
Health and related insurance for multinational employers, people working across borders, and employers and individuals in selected countries.
MD Live and EviCore care services
MD Live provides virtual medical and behavioral health visits; EviCore helps health plans manage coverage and care for certain medical services.
Cigna processes prescription claims and manages pharmacy networks and drug coverage for clients. It also runs home-delivery and specialty pharmacies, supplies specialty medicines to clinics and hospitals, and provides virtual care and medical care-management services. Its insurance business sells health coverage and administers employer health plans, including plans where the employer pays medical claims itself.
The Cigna Group şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.
The themes The Cigna is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$301,43-%0,611 Kas kapanış
30 Eylül 2026 tarihine kadarki rakamlar, 5 Kasım 2026 tarihinde sunulan 10-Q raporundan
Cigna sells prescription-drug benefits and pharmacy services to employers, health plans and government programs, plus medical insurance to employers and individuals.
Grade A
Fiyatın altındaki şerit, her tarihteki notu gösterir; yalnızca o tarihe kadar yayımlanmış belgelerden hesaplanır.
The Cigna Group şirketinin not geçmişinin 32 çeyreğinden 2 tanesi gösteriliyor. Diğer 30 çeyrek Şubat 2019 tarihine kadar uzanıyor.